Allspring Global Investments Holdings LLC Lowers Position in The Clorox Company (NYSE:CLX)

Allspring Global Investments Holdings LLC trimmed its holdings in The Clorox Company (NYSE:CLX - Free Report) by 17.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 112,691 shares of the company's stock after selling 23,493 shares during the period. Allspring Global Investments Holdings LLC owned about 0.09% of Clorox worth $16,668,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Brown Miller Wealth Management LLC bought a new position in Clorox in the 1st quarter worth approximately $399,000. Roman Butler Fullerton & Co. purchased a new stake in Clorox in the 1st quarter worth $400,000. Wedge Capital Management L L P NC lifted its stake in Clorox by 33.5% in the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock worth $4,198,000 after purchasing an additional 7,159 shares in the last quarter. Cornerstone Wealth Group LLC lifted its stake in Clorox by 19.0% in the 1st quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company's stock worth $3,767,000 after purchasing an additional 4,085 shares in the last quarter. Finally, Alpine Bank Wealth Management bought a new stake in shares of Clorox in the first quarter worth about $478,000. Institutional investors own 78.53% of the company's stock.

Clorox Trading Up 0.1%

Clorox stock traded up $0.14 during mid-day trading on Thursday, hitting $124.80. The company's stock had a trading volume of 1,078,076 shares, compared to its average volume of 1,397,254. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The company has a 50 day moving average of $130.17 and a 200-day moving average of $144.40. The Clorox Company has a one year low of $117.35 and a one year high of $171.37. The stock has a market cap of $15.38 billion, a PE ratio of 22.41, a P/E/G ratio of 3.01 and a beta of 0.51.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the company posted $1.71 earnings per share. The company's revenue for the quarter was down 8.0% on a year-over-year basis. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Barclays dropped their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. JPMorgan Chase & Co. decreased their price objective on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. UBS Group dropped their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Finally, Wells Fargo & Company decreased their price target on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $149.50.

Insider Activity at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director owned 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.57% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.